Scrapped Covid vaccine deal with Valneva cost UK taxpayers £358m

[ad_1]

A spokesman for Valneva said the firm was “exploring options for its Almeida manufacturing facility in Livingston, initially built to produce its Covid-19 vaccine, including a possible sale or a repurposing to produce its vaccine for Japanese Encephalitis, and its chikungunya vaccine, if approved”.

[ad_2]

Source link

Leave a Reply

Your email address will not be published.